Clinical evaluation of an innovative psma-targeted radiotherapy, CTT1403, in prostate cancer
Ended Project Grant Awarded Last action
- Award ID
- R44CA239461
- Recipient
-
Cancer Targeted Technology LLC UEI G2CENLL6M648
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,915,089
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $3,549,222.00 Federal
- $365,867.00 Non-federal
- Place of performance
- Woodinville, WA, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $365,867 | $0 | |
| Amendment | $365,867 | $365,867 | |
| Amendment | $1,441,580 | $0 | |
| Original award | $1,375,908 | $0 |
Quick answers
Who received award R44CA239461?
R44CA239461 was awarded to Cancer Targeted Technology LLC by National Cancer Institute (National Institutes of Health) on July 2, 2019.
How much is award R44CA239461 worth?
$3,915,089 has been obligated on R44CA239461: $3,549,222 in federal funding and $365,867 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award